In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ziprasidone HCl Drug Master File in Korea (Ziprasidone HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ziprasidone HCl. The MFDS reviews the Ziprasidone HCl KDMF as part of the drug registration process and uses the information provided in the Ziprasidone HCl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ziprasidone HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ziprasidone HCl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ziprasidone HCl suppliers with KDMF on PharmaCompass.